Global Medical Tourism Market Forecast to Reach $292.9 Billion by 2035
The global medical tourism market is entering a new growth cycle, driven by rising healthcare costs, long waiting lists, digital consultations, better international patient coordination, and the growing willingness of patients to travel abroad for affordable treatment.
According to Market Research Future’s latest medical tourism market report, updated on June 26, 2026, the global medical tourism market was valued at $49.28 billion in 2024 and is projected to grow from $58.25 billion in 2025 to $292.87 billion by 2035. That implies a compound annual growth rate of 18.2% between 2025 and 2035.
That forecast, if realized, would make medical tourism one of the fastest-growing segments of the global healthcare economy.
Why medical tourism is growing
Medical tourism is growing because patients are increasingly comparing healthcare globally.
For many people, the decision is not only about cost. It is also about speed, access, trust, technology, doctor reputation and the ability to receive treatment without long delays.
Market Research Future identifies several major drivers behind the market’s growth: lower treatment costs in developing countries, advanced procedures, modern hospital infrastructure, skilled physicians, improved travel connectivity and more personalized patient care.
The cost difference remains the most powerful driver.
In countries such as India, Thailand, Malaysia, Mexico, Turkey and the Philippines, many advanced procedures can cost significantly less than in the United States, Canada or Western Europe. Market Research Future notes that procedures such as cardiac surgery, orthopedics, cosmetic surgery, fertility treatment and dental care can often cost 50% to 80% less in developing medical tourism destinations, even after including travel and accommodation.
This price gap is especially important for patients who are uninsured, underinsured, facing high deductibles, or stuck on long public healthcare waiting lists.
Cosmetic surgery leads, but the market is broader than aesthetics
Cosmetic surgery remains the largest treatment category in global medical tourism.
According to the report, cosmetic surgery accounted for 28% of the medical tourism market in 2024, making it the largest treatment segment.
This is not surprising. Cosmetic procedures are often elective, planned in advance, easier to compare by price, and strongly influenced by social media, before-and-after marketing, and destination branding.
But medical tourism is much bigger than cosmetic surgery.
The report segments the market across several treatment categories, including:
- orthopedics
- ophthalmology
- oncology
- cosmetic surgery
- cardiovascular treatment
- dentistry
- neurology
- fertility treatment
- other medical services
Fertility treatment is highlighted as one of the fastest-growing segments for the forecast period.
That matters because the next stage of medical tourism may not be driven only by low-cost elective procedures. It may increasingly include IVF, oncology, cardiology, orthopedics, diagnostics, longevity, preventive medicine and complex care.
Private hospitals dominate medical tourism
Medical tourism is heavily driven by private healthcare providers.
Market Research Future estimates that the private healthcare segment held 72% of the medical tourism market in 2024. The report also expects private providers to remain the fastest-growing service-provider category during the forecast period.
This reflects how international patient care usually works in practice.
Private hospitals and clinic groups are often better positioned to serve foreign patients because they can offer:
- international patient departments
- multilingual coordinators
- faster appointment scheduling
- premium rooms
- transparent package pricing
- airport transfers
- hotel coordination
- teleconsultations before travel
- follow-up support after treatment
For international patients, the treatment itself is only one part of the decision. The full journey matters: consultation, pricing, travel planning, hospital admission, translation, discharge, recovery and aftercare.
This is why private hospital groups in countries such as Turkey, India, Thailand, South Korea, Malaysia, Mexico and the UAE are investing heavily in international patient units.
The next growth engine: telemedicine and cross-border partnerships
One of the most important trends in the report is the expansion of telemedicine and virtual consultations.
Medical tourism used to start when the patient arrived in the destination country. Now, it starts much earlier.
Patients can send medical records, X-rays, lab results, MRI scans, dental images, photographs or previous diagnoses before traveling. Doctors can review files remotely. Hospitals can issue preliminary treatment plans. Coordinators can explain costs, recovery time and travel requirements before the patient books a flight.
Market Research Future identifies telemedicine and virtual consultations as a key opportunity for the medical tourism market, alongside cross-border hospital partnerships.
This changes the business model.
The winning medical tourism providers will not only be hospitals with good doctors. They will be the providers that can build trust before the patient travels.
That means fast response times, clear communication, transparent pricing and credible remote evaluation will become major competitive advantages.
Medical tourism is becoming a healthcare network business
The report also highlights hospital expansion and patient networks as important growth factors.
Major medical tourism players mentioned in the report include Fortis Healthcare, Apollo Hospitals, Bumrungrad International Hospital, Medanta, Bangkok Hospitals, Raffles Medical Group and Asklepios Kliniken.
This shows that medical tourism is becoming more institutional.
The market is not only about individual clinics or one-time patient referrals. It is increasingly about hospital groups, international offices, insurance relationships, facilitator networks, government promotion, accreditation systems and digital patient acquisition.
Large hospital groups have several advantages:
- stronger brand trust
- broader specialty coverage
- better complication management
- more international coordinators
- deeper referral networks
- easier partnerships with governments, insurers and facilitators
- more ability to invest in technology and patient experience
This trend is important for destinations like Turkey, India, Thailand, South Korea, Malaysia, Mexico and the UAE. The next competition will not only be about which country is cheaper. It will be about which hospital groups can deliver the most reliable international patient journey.
Regional competition is intensifying
The global medical tourism map is becoming more competitive.
Asia-Pacific remains one of the most important medical tourism regions, with countries such as Thailand, India, Malaysia and South Korea attracting patients for cosmetic surgery, cardiac care, orthopedics, fertility treatment, wellness and advanced medical procedures. Market Research Future notes that Thailand, India, Malaysia and South Korea have attracted millions of patients seeking lower-cost but high-quality care across multiple specialties.
North America is also central to the market, especially because high U.S. healthcare costs push patients toward nearby destinations such as Mexico, as well as farther destinations for dental, cosmetic and surgical care.
Europe’s medical tourism market is shaped by long waiting lists, cross-border healthcare access and patients seeking faster treatment abroad. The report notes that UK patients increasingly traveled abroad after COVID-19, with around 350,000 UK residents traveling abroad for procedures in 2022, up from around 248,000 in 2019.
The Middle East is also becoming more important. Dubai, in particular, has positioned itself as a high-end healthcare destination. Market Research Future states that Dubai attracted approximately 691,000 medical tourists in 2023, with around AED 1 billion spent on medical treatments.
This means the future of medical tourism will be more competitive, not less.
Patients will have more destination choices. Countries will need clearer positioning. Hospitals will need stronger trust signals. Facilitators will need better service quality. And governments will need to improve regulation, data transparency and patient protection.
The market’s biggest risk: trust
The report also points to quality, safety, ethical concerns, post-surgery complications and follow-up care as restraints on medical tourism growth.
This is the key issue.
Medical tourism can save patients money and improve access. But when something goes wrong, the patient may be far from the doctor, outside their home legal system, and uncertain about who is responsible for follow-up.
That is why trust will become the most valuable currency in medical tourism.
Low prices may attract attention, but safe outcomes, transparent communication and responsible aftercare will build sustainable brands.
For hospitals, clinics and facilitators, the lesson is clear: growth will not only come from more advertising. It will come from better systems.
Conclusion
The global medical tourism market is projected to grow from $58.25 billion in 2025 to $292.87 billion by 2035, according to Market Research Future.
That forecast reflects a major shift in global healthcare behavior. Patients are becoming more willing to travel for treatment, especially when healthcare at home is expensive, delayed or difficult to access.
But the next decade of medical tourism will not be defined only by cheap surgery. It will be defined by trust, technology, patient experience, cross-border coordination and the ability to deliver safe, high-quality care across borders.
For destinations like Turkey, India, Thailand, Mexico, South Korea, Malaysia and Dubai, the opportunity is enormous. But so is the competition.
The winners will be the countries, hospitals and facilitators that can make international healthcare feel not only affordable, but safe, transparent and professionally managed.
